In brief, in the present study, we analyzed HCC patient data from different databases and systematically revealed that the expression of RPL32 in HCC samples was significantly higher than that in normal tissue samples, which was associated with a lower survival probability in HCC patients. This evidence concerns the gene RPL32 and hepatocellular carcinoma.